Relying on R&D and innovation, the company actively promoted the comprehensive utilization of xamvalene by-products, and creatively developed synthesis processes for three excellent types of pesticides, methoxytrazide, fluorophenylamide, and oxazolidone, using by-products generated in the synthesis of xamphenicolol intermediates, and comprehensively formed a unique industrial chain layout within the “1+3” industry. The company's current industrial chain covers pesticide pharmaceutical intermediates, pesticide raw materials and pesticide preparations, and has a complete scientific research and development, intermediate production, original drug synthesis and formulation processing system. The main products are the original drugs, intermediates, and preparations of the environmentally friendly, high-efficiency, and low-toxic pesticide ximeveling. It is the only leading domestic segmented enterprise with production and development capabilities for the entire xamphenicol, intermediate, and formulation industry chain. At the same time, the company relied on R&D and innovation to actively promote the comprehensive utilization of xylvalene by-products, successfully developed a complete low-cost synthesis process for the excellent insecticide methoxycaprozidine, and successfully obtained the original drug registration of the insecticide methoxylamide. Company honors: 2017 Outstanding Growth Enterprise, 2017 Top 100 Taxpayer Enterprises, 2017 Top 50 Comprehensive Industrial Strength Enterprises, 2016 Outstanding Growth Enterprise, 2016 Top 100 Comprehensive Industrial Strength Enterprises, etc.
No Data